Tenofovir does not induce renal dysfunction compared to entecavir in post-liver-transplant hepatitis B virus patients.
Sang-Jin KimJinsoo RhuSeo Hee LeeJong Man KimGyu Seong ChoiKyunga KimJae-Won JohPublished in: Annals of surgical treatment and research (2020)
Tenofovir disoproxil fumarate does not induce renal dysfunction in liver-transplanted patients with HBV more than does entecavir.